1755P Multimodal therapy in first line treatment of very high risk Ewing sarcoma patients: Results of the French prospective multicenter COMBINAIR3 phase II trial.
Saved in:
| Title: | 1755P Multimodal therapy in first line treatment of very high risk Ewing sarcoma patients: Results of the French prospective multicenter COMBINAIR3 phase II trial. |
|---|---|
| Authors: | Laurence, V.1 (AUTHOR), Cordero, C.2 (AUTHOR), Dureau, S.3 (AUTHOR), Jehanno, N.4 (AUTHOR), Pierron, G.5 (AUTHOR), Gaspar, N.6 (AUTHOR), Valentin, T.7 (AUTHOR), Revon-Riviere, G.8 (AUTHOR), Lervat, C.9 (AUTHOR), Taque, S.10 (AUTHOR), Entz-Werle, N.11 (AUTHOR), Mansuy, L.12 (AUTHOR), Plantaz, D.13 (AUTHOR), Rios, M.14 (AUTHOR), Saumet, L.15 (AUTHOR), Verite, C.16 (AUTHOR), Castex, M-P.17 (AUTHOR), Thebaud, E.18 (AUTHOR), Brahmi, M.19 (AUTHOR), Corradini, N.20 (AUTHOR) |
| Source: | Annals of Oncology. 2024 Supplement 2, Vol. 35, pS1046-S1046. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2024.08.1846 |
